I hope it does, there are a few ASX listed bios sitting on RPDDs.
I guess I still don't understand why, after being awarded RPDD back in July 2018, Race didn't immediately design 1 or 2 Paediatric AML trials with guidance from the FDA to get approval. Surely 50 previous clinical trials worth of safety and efficacy data would have made that relatively easy to do?
Imagine that, Race could be close to FDA approval in Paediatric AML by now, providing ongoing revenue and $50-100m from the sale of a PRV!
That would provide funding for RC220 with some leftover for shareholders.
Or is all that data from 50 clinical trials not very compelling? That's a tonne of trials!
Anyway, I continue to watch with interest (and some confusion). CP is why I'm still interested and probably why many more recent investors are here.
- Forums
- ASX - By Stock
- RAC
- RAC - Charts & Price Action
RAC - Charts & Price Action, page-18226
-
- There are more pages in this discussion • 4,378 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.66 |
Change
-0.030(1.78%) |
Mkt cap ! $284.6M |
Open | High | Low | Value | Volume |
$1.69 | $1.69 | $1.66 | $16.21K | 9.729K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 969 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 2 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 969 | 1.650 |
2 | 1775 | 1.630 |
2 | 12062 | 1.605 |
1 | 4000 | 1.600 |
3 | 2932 | 1.580 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 400 | 1 |
1.665 | 30 | 1 |
1.685 | 4481 | 1 |
1.690 | 2316 | 1 |
1.730 | 968 | 1 |
Last trade - 11.26am 07/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |